deaths related to semaglutide reduces risk of all-cause death FDA warns Novo Nordisk of

Orange Peel Oil: A natural source of antioxidants, polyphenols, and vitamin C, helps to fade dark spots and reduce dark circles

Paracetamol: Past, present, and future

FDA approves weight loss drug Zepbound to treat obstructive sleep apnea The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive sleep apnea

GLP-1 receptor agonists have become a leading treatment option for weight management, with clinical trials showing an average weight loss of 15-22% over 68 weeks

Evaluating Weight Loss Pill Options: Considerations by Circumstance Based on clinical trial data, regulatory status, and access considerations, the following framework outlines factors patients may discuss with their healthcare providers

For a 250-pound patient, that could mean losing 37 to 42 pounds